Patents matching “SION”

US 6709858

Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

Arizona Board of Regents on Behalf of the University of Arizona · Granted Mar 23, 2004 · Expires Mar 18, 2024

US 6710073

Drugs to improve synaptic transmission

The Regents of the University of California · Granted Mar 23, 2004 · Expires Mar 18, 2024

US 6699674

Expression and refolding of truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi and its use in antibody based detection assays and vaccines

United States of America as represented by the Secretary of the Air Force · Granted Mar 2, 2004 · Expires Feb 26, 2024

US 6692750

Alphavirus expression vector

Bioption AB · Granted Feb 17, 2004 · Expires Feb 12, 2024

US 6693130

Inhibitors of epoxide hydrolases for the treatment of hypertension

The Regents of the University of California · Granted Feb 17, 2004 · Expires Feb 12, 2024

US 6689561

Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment

The Regents of the University of California · Granted Feb 10, 2004 · Expires Feb 5, 2024

US 6685626

Compositions, devices, methods, and kits for induction of adhesions

Regeneration Technologies, Inc. · Granted Feb 3, 2004 · Expires Jan 29, 2024

US 6682741

&bgr;2 microglobulin fusion proteins and high affinity variants

The United States of America, as represented by the Department of Health and Human Services · Granted Jan 27, 2004 · Expires Jan 22, 2024

US 6673559

Met proto-oncogene and a method for predicting breast cancer progression

The United States of America as Represented by the Government of the Department of Health and Human Services · Granted Jan 6, 2004 · Expires Jan 1, 2024

US 6670374

Swainsonine compounds as inhibitors of toxin receptor expression

The United States of America, as represented by the Secretary of Agriculture · Granted Dec 30, 2003 · Expires Dec 25, 2023

US 6642049

Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38-bone marrow stem cells

United States of America as represented by the Secretary of the Air Force · Granted Nov 4, 2003 · Expires Oct 30, 2023

US 6632628

Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

The Board of Regents of the University of Texas System · Granted Oct 14, 2003 · Expires Oct 9, 2023

US 6630344

Diminishing viral gene expression by promoter replacement

Texas Systems, University of the Board of the Regents · Granted Oct 7, 2003 · Expires Oct 2, 2023

US 6630167

Hyaluronic acid anti-adhesion barrier

United States Surgical Corporation · Granted Oct 7, 2003 · Expires Oct 2, 2023

US 6613757

COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY

The Board of Regents of the University of Texas System · Granted Sep 2, 2003 · Expires Aug 28, 2023

US 6607882

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. · Granted Aug 19, 2003 · Expires Aug 14, 2023

US 6600030

Delayed progression to aids by a missense allele of the CCR2 gene

The United States of America, as represented by the Department of Health and Human Services · Granted Jul 29, 2003 · Expires Jul 24, 2023

US 6599744

Viral expression vectors comprising a ribosomal promoter sequence

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 29, 2003 · Expires Jul 24, 2023

US 6592872

Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein

The United States of America, as represented by the Department of Health and Human Services · Granted Jul 15, 2003 · Expires Jul 10, 2023

US 6589507

Foaming antacid suspension tablets

DR. Regenold GmbH · Granted Jul 8, 2003 · Expires Jul 3, 2023

US 6566342

Gene therapy by secretory gland expression

The Regents of the University of California · Granted May 20, 2003 · Expires May 15, 2023

US 6562347

Chemokine-tumor antigen fusion proteins as cancer vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted May 13, 2003 · Expires May 8, 2023

US 6534310

Suppression of proteolytic activity by dysfunctional protease formation

The Regents of the University of California · Granted Mar 18, 2003 · Expires Mar 13, 2023

US 6534261

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. · Granted Mar 18, 2003 · Expires Mar 13, 2023